Clinical Trials | August 28, 2023
Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Jeet will be a trusted partner in cardiovascular care
CiplaMed 2.0 leverages advanced analytics and automation
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
